project id: TCGA-HNSC; case submitter id: TCGA-BB-8601; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 8.8; age at index: 84; days to birth: -30721; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1926; age at diagnosis: 30721; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 624.0; icd 10 code: C04.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Floor of mouth, NOS; synchronous malignancy: No; tissue or organ of origin: Floor of mouth, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Yes; is ffpe: false; weight: 41.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 0.8; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-BB-8601-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 80.0;